​

Funding Round

Series A - Vernal Biosciences

Series A - Vernal Biosciences

Investment Firm

Overview

Vernal Biosciences specializes in high-purity mRNA for research and clinical use.

Announced Date

Jun 27, 2023

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Charles River Laboratories International

Charles River Laboratories International

Charles River Laboratories International is a post_ipo firm.

Ampersand Capital Partners

Ampersand Capital Partners

Ampersand Capital Partners is a debt and early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorDynamk Capital
Participant InvestorVermont Center for Emerging Technologies
Participant InvestorAmpersand Capital Partners
Participant InvestorCharles River Laboratories International

Round Details and Background

Vernal Biosciences raised $20000000 on 2023-06-27 in Series A

Vernal Biosciences specializes in high-purity mRNA for research and clinical use.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 12, 2021
Seed Round - Vernal Biosciences
2-undefined
Jun 02, 2022
Series A - Vernal Biosciences
5-21.0M
Jun 27, 2023
Series A - Vernal Biosciences
4-20.0M

Recent Activity

There is no recent news or activity for this profile.